Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $4.11 USD
Change Today -0.09 / -2.14%
Volume 429.8K
THLD On Other Exchanges
As of 8:10 PM 09/1/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Harold E. Selick Ph.D.

Executive Chairman and Chief Executive Officer,Threshold Pharmaceuticals Inc.
AgeTotal Calculated CompensationThis person is connected to 53 board members in 7 different organizations across 10 different industries.

See Board Relationships
As of Fiscal Year 2014


Dr. Harold E. Selick, also known as Barry, Ph.D., has been the Executive Chairman and Chief Executive Officer of Threshold Pharmaceuticals Inc., since June 2002. Dr. Selick is a Venture Partner at Sofinnova Ventures, Sofinnova Venture Partners VI, L.P., Sofinnova Venture Partners VII, L.P. He co-founded Epiphany Biosciences, Inc. in 2001. His knowledge is based to a large extent on firsthand experience. Previously, he was the Co-Founder, President, and Chief Executive ...

Read Full Background

Corporate Headquarters*

170 Harbor Way
South San Francisco, California 94080

United States

Phone: 650-474-8200
Fax: 650-474-2529

Board Members Memberships*

Chairman and Independent Director
Executive Chairman and Chief Executive Officer
Director, Chairman of Compensation Committee, Chairman of Nominating & Governance Committee, Member of Litigation Committee and Member of Audit Committee


The University of Pennsylvania
BA 1983
The University of Pennsylvania

Other Affiliations*

Annual Compensation*

Total Annual Compensation$575,000

Stock Options*

All Other Compensation$1,980
Exercisable Options1,734,893
Exercisable Options Value$2,275,864
Unexercisable Options638,439
Unexercisable Options Value$77,000
Total Value of Options$2,352,864
Total Number of Options2,373,332

Total Compensation*

Total Annual Cash Compensation$847,230
Total Short Term Compensation$575,000
Other Long Term Compensation$1,980
Total Calculated Compensation$1,752,225
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
THLD:US $4.11 USD -0.09


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact THRESHOLD PHARMACEUTICALS, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at